| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial. | Neuro Oncol | 2010 | 1.31 |
| 2 | Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers. | Acta Oncol | 2011 | 0.80 |
| 3 | Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab. | Cancer Biol Ther | 2011 | 0.78 |
| 4 | [Gender differences among medical students in the approach to simulation]. | Ugeskr Laeger | 2011 | 0.78 |
| 5 | Poor countries left behind in rush to claim sea floor. | Nature | 2008 | 0.75 |